Previous close | 564.00 |
Open | 564.26 |
Bid | 0.00 x 800 |
Ask | 0.00 x 900 |
Day's range | 552.18 - 565.00 |
52-week range | 373.28 - 566.16 |
Volume | |
Avg. volume | 675,520 |
Market cap | 71.803B |
Beta (5Y monthly) | 0.45 |
PE ratio (TTM) | 24.69 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 2.48 (0.45%) |
Ex-dividend date | 03 Jun 2024 |
1y target est | N/A |
Investors are optimistic about McKesson's (MCK) strength in its Biologics business.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Investors in McKesson Corporation ( NYSE:MCK ) had a good week, as its shares rose 2.4% to close at US$544 following...